Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!

Reach out to AET – Tiefenbacher Group at BePharma the most important Pharma B2B Event in Latin America from October 10-12!

Discover our latest product portfolio in Mexico City and find out how we strive to make pharmaceuticals more affordable, more available, and better than before!

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com

Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!

Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!

About Tiefenbacher Group – Pioneering Healthcare since 1963

ISO 13485 compliant

Highest quality standards

Combining medicaldevices and e-health

Best-in-class solution

100% Patient-centric

closer to the patient than ever before

First NCE approved

Always striving for better therapies

Frequent day-one launches

market entry at the earliest possible time

Regulatory Affairs (RA)

abundant practical experience: from development to maintenance

350+ tender awards in 12 month

Strong track record of successful tender proposals

150+ marketing partners on five continents

collective power to succeed

80+ countries worldwide

Global market access of generic, value added, and innovative products

15.000+ MAs obtained

FDF marketing authorizations and maintenance

Generic, value added, and innovative drugs

New generation of pharmaceuticals I Flexible technological fit

efficiency driven supply chain management

from API to finished product I Excellence beyond Manufacturing

own state-of-the-art production sites

broad range of technologies including highly potent drugs

small batch and high-volume production

flexible capacities

SPC waiver site in EU (Cyprus)

Internationally competitive manufacturing site based in the EU

up to 3 bn units p.y. production capacity

Industry-Leading in on-time delivery I Capacities and capabilities

GMP compliance including FDA

good manufacturing practices (GMP)

Product safety & quality for high-quality FDF

manufacturing of high-quality pharmaceuticals products

Own GMP-warehouse

Storage + European hub for APIs & narcotics

250+ European customers

Serving the needs of pharmaceutical industry

600+ APIs (Human + Animal)

Broad portfolio raw material

100% After Sales Service

Life cycle + maintenance

100+ audits

supplier qualification I inhouse capacity

Quality assurance (QA) + Regulatory Affairs (RA)

Global regulatory + compliance

130+ manufacturers

multiple sourcing options

100% entire pharmaceutical value chain

GDP (Good Distribution Practice) with on-time delivery

10+ Dosage forms

several types

generics

cost-efficient generic drug development

Value added and innovation medicines

New generation of pharmaceuticals

major indications and highly potent drugs

an innovative portfolio pipeline

150+ R&D Scientists

our center of excellence

180+ FDF Products

Dossiers developed /under development

quality assurance and intellectual property

legal framework & compliance

Own laboratories with FDA approved

stat-of-the-art inhouse development

180+ FDF Products

Dossiers developed /Under development

80+ countries worldwide

Medical innovations & healthcare solutions

Family owned

Pioneering healthcare since 1963

Pioneering Healthcare

Since 1963

100% entire pharmaceutical value chain

Combining medical
devices and e-health

Highly efficient R&D
project management

Affordable medical
devices